A detailed mammosphere assay protocol for the quantification of breast stem cell activity - PubMed (original) (raw)

Review

A detailed mammosphere assay protocol for the quantification of breast stem cell activity

Frances L Shaw et al. J Mammary Gland Biol Neoplasia. 2012 Jun.

Abstract

Since the discovery that neural tissue contains a population of stem cells that form neurospheres in vitro, sphere-forming assays have been adapted for use with a number of different tissue types for the quantification of stem cell activity and self-renewal. One tissue type widely used for stem cell investigations is mammary tissue, and the mammosphere assay has been used in both normal tissue and cancer. Although it is a relatively simple assay to learn, it can be difficult to master. There are methodological and analytical aspects to the assay which require careful consideration when interpreting the results. We describe here a detailed mammosphere assay protocol for the assessment of stem cell activity and self-renewal, and discuss how data generated by the assay can be analysed and interpreted.

PubMed Disclaimer

Similar articles

• Determining mammosphere-forming potential: application of the limiting dilution analysis.
  Rota LM, Lazzarino DA, Ziegler AN, LeRoith D, Wood TL. Rota LM, et al. J Mammary Gland Biol Neoplasia. 2012 Jun;17(2):119-23. doi: 10.1007/s10911-012-9258-0. Epub 2012 Jun 8. J Mammary Gland Biol Neoplasia. 2012. PMID: 22678420 Free PMC article. Review.
• Mammary stem cells and breast cancer--role of Notch signalling.
  Farnie G, Clarke RB. Farnie G, et al. Stem Cell Rev. 2007 Jun;3(2):169-75. doi: 10.1007/s12015-007-0023-5. Stem Cell Rev. 2007. PMID: 17873349 Review.
• In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity.
  Smart CE, Morrison BJ, Saunus JM, Vargas AC, Keith P, Reid L, Wockner L, Askarian-Amiri M, Sarkar D, Simpson PT, Clarke C, Schmidt CW, Reynolds BA, Lakhani SR, Lopez JA. Smart CE, et al. PLoS One. 2013 Jun 4;8(6):e64388. doi: 10.1371/journal.pone.0064388. Print 2013. PLoS One. 2013. PMID: 23750209 Free PMC article.
• Assays for functionally defined normal and malignant mammary stem cells.
  Aalam SMM, Beer PA, Kannan N. Aalam SMM, et al. Adv Cancer Res. 2019;141:129-174. doi: 10.1016/bs.acr.2018.12.004. Epub 2019 Jan 17. Adv Cancer Res. 2019. PMID: 30691682 Review.
• Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.
  Paranjape AN, Mandal T, Mukherjee G, Kumar MV, Sengupta K, Rangarajan A. Paranjape AN, et al. Oncogene. 2012 Apr 12;31(15):1896-909. doi: 10.1038/onc.2011.378. Epub 2011 Aug 29. Oncogene. 2012. PMID: 21874052

Cited by

• Targeting tumor-initiating cells: eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction.
  Lamb R, Harrison H, Smith DL, Townsend PA, Jackson T, Ozsvari B, Martinez-Outschoorn UE, Pestell RG, Howell A, Lisanti MP, Sotgia F. Lamb R, et al. Oncotarget. 2015 Mar 10;6(7):4585-601. doi: 10.18632/oncotarget.3278. Oncotarget. 2015. PMID: 25671304 Free PMC article.
• Upregulation of Receptor Tyrosine Kinase Activity and Stemness as Resistance Mechanisms to Akt Inhibitors in Breast Cancer.
  Tsang T, He Q, Cohen EB, Stottrup C, Lien EC, Zhang H, Lau CG, Chin YR. Tsang T, et al. Cancers (Basel). 2022 Oct 13;14(20):5006. doi: 10.3390/cancers14205006. Cancers (Basel). 2022. PMID: 36291790 Free PMC article.
• Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts.
  Tisza MJ, Zhao W, Fuentes JS, Prijic S, Chen X, Levental I, Chang JT. Tisza MJ, et al. Oncotarget. 2016 Aug 9;7(32):51553-51568. doi: 10.18632/oncotarget.9928. Oncotarget. 2016. PMID: 27303921 Free PMC article.
• Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
  De Luca A, Fiorillo M, Peiris-Pagès M, Ozsvari B, Smith DL, Sanchez-Alvarez R, Martinez-Outschoorn UE, Cappello AR, Pezzi V, Lisanti MP, Sotgia F. De Luca A, et al. Oncotarget. 2015 Jun 20;6(17):14777-95. doi: 10.18632/oncotarget.4401. Oncotarget. 2015. PMID: 26087310 Free PMC article.
• Metabolic determination of cell fate through selective inheritance of mitochondria.
  Döhla J, Kuuluvainen E, Gebert N, Amaral A, Englund JI, Gopalakrishnan S, Konovalova S, Nieminen AI, Salminen ES, Torregrosa Muñumer R, Ahlqvist K, Yang Y, Bui H, Otonkoski T, Käkelä R, Hietakangas V, Tyynismaa H, Ori A, Katajisto P. Döhla J, et al. Nat Cell Biol. 2022 Feb;24(2):148-154. doi: 10.1038/s41556-021-00837-0. Epub 2022 Feb 14. Nat Cell Biol. 2022. PMID: 35165416 Free PMC article.

References

1. 1. J Natl Cancer Inst. 2008 May 7;100(9):672-9 - PubMed
2. 1. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8 - PubMed
3. 1. Breast Cancer Res. 2008;10(3):R52 - PubMed
4. 1. J Natl Cancer Inst. 2007 Apr 18;99(8):616-27 - PubMed
5. 1. Nature. 2009 Apr 9;458(7239):780-3 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information